Literature DB >> 10663613

gammadelta T cells lyse autologous and allogenic oesophageal tumours: involvement of heat-shock proteins in the tumour cell lysis.

M L Thomas1, U C Samant, R K Deshpande, S V Chiplunkar.   

Abstract

T cells expressing gammadelta receptors were isolated from the peripheral blood of oesophageal cancer patients and analysed for their potential to lyse tumour targets. Immunophenotyping by flow cytometry showed that the dominant population of gammadelta T cells expressed the Vgamma9 and the Vdelta2 T cell receptor, and a minor population expressed the Vdelta1 receptor. Cytotoxicity assays revealed that activated gammadelta T cells lysed Daudi Burkitt's lymphoma and K562 cells. Lysis of autologous oesophageal tumours was higher than of allogenic tumours. Anti-hsp60 and anti-hsp70 mAb significantly inhibited the cytotoxicity of gammadelta T cells to both autologous and allogenic oesophageal tumours. Surface expression of hsp60 and hsp70 on oesophageal tumours and Daudi cells was demonstrated by flow cytometry. In conclusion, gammadelta T cells isolated from the peripheral blood of oesophageal cancer patients have the ability of kill oesophageal tumour cells. The lysis of tumour targets by the gammadelta T cells is brought about via recognition of heat-shock proteins expressed on the surface of tumour cells. gammadelta T cells isolated from the peripheral blood may have applications in adoptive immunotherapy of oesophageal cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10663613     DOI: 10.1007/s002620050014

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  11 in total

1.  Expression of 60 kDa heat shock protein (Hsp60) on plasma membrane of Daudi cells.

Authors:  Rosella Cicconi; Andrea Delpino; Pierluca Piselli; Mauro Castelli; Daniela Vismara
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

2.  Individual Vgamma2-Jgamma1.2+ T cells respond to both isopentenyl pyrophosphate and Daudi cell stimulation: generating tumor effectors with low molecular weight phosphoantigens.

Authors:  Andrew M Hebbeler; Cristiana Cairo; Jean Saville Cummings; C David Pauza
Journal:  Cancer Immunol Immunother       Date:  2006-11-28       Impact factor: 6.968

3.  Serum heat shock protein 60 can predict remission of flare-up in juvenile idiopathic arthritis.

Authors:  Chih-Te Charles Wu; Liang-Shiou Ou; Kuo-Wei Yeh; Wen-I Lee; Jing-Long Huang
Journal:  Clin Rheumatol       Date:  2011-02-22       Impact factor: 2.980

4.  Purification of heat shock protein 70-associated tumor peptides and their antitumor immunity to hepatoma in mice.

Authors:  Dai-Xiong Chen; Yan-Rong Su; Gen-Ze Shao; Zhen-Chao Qian
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

Review 5.  Circulating heat shock protein 70 (HSPA1A) in normal and pathological pregnancies.

Authors:  Attila Molvarec; Lilla Tamási; György Losonczy; Krisztina Madách; Zoltán Prohászka; János Rigó
Journal:  Cell Stress Chaperones       Date:  2009-10-12       Impact factor: 3.667

Review 6.  The Jekyll and Hyde story of IL17-Producing γδT Cells.

Authors:  Rushikesh S Patil; Sajad A Bhat; Asif A Dar; Shubhada V Chiplunkar
Journal:  Front Immunol       Date:  2015-02-04       Impact factor: 7.561

Review 7.  Insights into the Relationship between Toll Like Receptors and Gamma Delta T Cell Responses.

Authors:  Asif Amin Dar; Rushikesh Sudam Patil; Shubhada Vivek Chiplunkar
Journal:  Front Immunol       Date:  2014-07-31       Impact factor: 7.561

8.  Activation status of γδ T cells dictates their effect on osteoclast generation and bone resorption.

Authors:  Swati P Phalke; Shubhada V Chiplunkar
Journal:  Bone Rep       Date:  2015-10-23

Review 9.  Chlamydia trachomatis infection and anti-Hsp60 immunity: the two sides of the coin.

Authors:  Francesco Cappello; Everly Conway de Macario; Valentina Di Felice; Giovanni Zummo; Alberto J L Macario
Journal:  PLoS Pathog       Date:  2009-08-28       Impact factor: 6.823

Review 10.  Targeting gamma delta T cells for cancer immunotherapy: bench to bedside.

Authors:  Dimpu Gogoi; Shubhada V Chiplunkar
Journal:  Indian J Med Res       Date:  2013-11       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.